These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 234643)

  • 1. [Fibrin (ogen) Split products of nephropathies].
    Anger H
    Urologe A; 1975 Jan; 14(1):20-4. PubMed ID: 234643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of coagulation in renal disease.
    MacDonald MK; Clarkson AR; Davison AM
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):809-28. PubMed ID: 4807810
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrin in renal disease: functional considerations.
    Wardle EN
    Clin Nephrol; 1974; 2(3):85-92. PubMed ID: 4604477
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of serum and urine fibrin split products and urinary beta-glucuronidase in the diagnosis of renal transplant rejection.
    Gonick HC; Stiehm ER; Saldanha LF
    Curr Probl Clin Biochem; 1979; (9):257-72. PubMed ID: 376226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal disease and fibrinogen degradation products.
    Hedner U; Nilsson IM
    Adv Nephrol Necker Hosp; 1974; 3():241-71. PubMed ID: 4219704
    [No Abstract]   [Full Text] [Related]  

  • 6. Binding of urinary protein C inhibitor to fibrin(ogen) and its binding mechanism.
    Hayashi S; Yamada K
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):153-8. PubMed ID: 8384496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Coagulation and anticoagulants in renal processes].
    Garciá FL
    Rev Clin Esp; 1975 May; 137(4):293-9. PubMed ID: 1096249
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
    Bendel M; Oetliker O; Montandon A; Beck EA
    Schweiz Med Wochenschr; 1975 Aug; 105(33):1040-7. PubMed ID: 1099647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin-fibrinogen degradation products in children with renal disease.
    Ambrus JL; Baliah T; Ambrus CM; Mink IB; Murphy GP
    N Y State J Med; 1974 Jul; 74(8):1396-402. PubMed ID: 4277485
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
    Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M
    J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary fibrin split products in lupus nephritis.
    Zizic TM; Cwazka WF; Young NS; Stevens MB
    J Rheumatol; 1976 Mar; 3(1):43-9. PubMed ID: 775087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary fibrin split products in human renal disease.
    Stiehm ER; Kuplic LS; Uehling DT
    J Lab Clin Med; 1971 May; 77(5):843-52. PubMed ID: 5557667
    [No Abstract]   [Full Text] [Related]  

  • 13. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
    Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
    Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble crosslinked fibrin(ogen) polymers.
    Selmayr E; Müller-Berghaus G
    Thromb Haemost; 1985 Dec; 54(4):804-7. PubMed ID: 4089815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary fibrin-fibrinogen degradation products and intraglomerular fibrin-fibrinogen deposition in various renal diseases.
    Kamitsuji H; Tani K; Taniguchi A; Masuyama H; Iida Y; Fukui H
    Thromb Res; 1981 Feb; 21(3):285-94. PubMed ID: 7245140
    [No Abstract]   [Full Text] [Related]  

  • 16. Problems of diagnosis of disseminated intravascular coagulation (DIC).
    Bowie EJ; Owen CA
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):325-7. PubMed ID: 515796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of fibrin-stabilizing factor (F XIIIA and S), fibrinogen-related antigens, fibrinogen degradation products (FDPd and FDPe) and antihemolytic factor (F VIII) in renal disease: analysis of 161 cases by immunofluorescence microscopy.
    Colasanti G; Morel Maroger L; D'Amico G
    Clin Nephrol; 1987 Jul; 28(1):28-34. PubMed ID: 3113791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of determining urinary fibrin split products in glomerulonephritis, pyelonephritis and graft rejection].
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Z Urol Nephrol; 1978 Nov; 71(11):787-97. PubMed ID: 366978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of fibrinolysis in chronic subdural hematoma].
    Trappe A; Hafter R; Wendt P; Graeff H; Blümel G
    Neurochirurgia (Stuttg); 1986 May; 29(3):78-82. PubMed ID: 3724938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.